Its being studied for more (addiction, mental health, Alzheimers) Prices are coming down (Zepbound is 20% less expensive than Wegovy) But, on the other hand: Medicare is legally prevented from covering GLP1s for obesity Only 16 states cover anti-obesity medications under Medicaid 50% or less commercial plans cover GLP1s for obesity, and those that do often have unreasonable hurdles Covered can still mean $500-1000 out of pocket every month
Noom users on a GLP-1 lose 1.4x more weight than those on medication alone*, and in Noom's largest randomized controlled trial of its digital behavior program, members lost an average of 4.1% of their body weight and kept losing for a full year after the program ended, while a control group gained weight
doi: 10.1016/j.peptides.2015.06.006 89 Toft-NielsenMBDamholtMBMadsbadSHilstedLMHughesTEMichelsenBKet al
Research on L-Carnitine supplementation hasn't always shown consistent results in terms of performance or weight loss outcomes
Last process review: June 10, 2026